en · de · es · fr · pt
aod-9604-notes.peptides4088.com › Faq › Background And Molecular Identity — Quick Reference

Background And Molecular Identity — Quick Reference

By Editorial Desk · published 2026-04-26 · last reviewed 2026-05-27 · Faq

lyophilized powder comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-05-27. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Molecular Identity

The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.

Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.

AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.

Identity and Research Context

Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.

AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.

Aod-9604 at a glance

PropertyValueNotes
Molecular classSynthetic peptideBased on the C-terminal region of human growth hormone.
Amino acid length16 residuesOften described as hGH fragment 176-191.
AppearanceLyophilized powderTypically white to off-white; exact appearance depends on grade.
SolubilitySoluble in waterAqueous solubility depends on pH, ionic strength, and preparation.
Typical storage-20 °C or lowerLyophilized peptide is usually kept cold and dry; solutions may require freezing.

Handling And Analytical Properties

Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.

Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.

Related pages on this site

Background And Research Context

In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.

AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.

Handling, Analysis, and Quality Control

Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.

Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.

Regulatory and Analytical Context

In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.

Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.

Further detail

In October and December 1994, King Crimson recorded their eleventh studio album, Thrak, at Peter Gabriel's Real World Studios. Containing revised versions of the songs from Vrooom, plus some new tracks, the album was described by Q magazine as having "jazz-scented rock structures, characterised by noisy, angular, exquisite guitar interplay" and an "athletic, ever-inventive rhythm section", while being in tune with the sound of alternative rock of the mid-1990s. Examples of the band's efforts to integrate their multiple elements could be heard on the accessible (but complex) songs "Dinosaur" and "Sex Sleep Eat Drink Dream", the more straightforward ballad "One Time", as well as "Radio I" and "Radio II"- a pair of Fripp's Soundscapes instrumentals. King Crimson resumed touring in 1995 and into 1996. Dates from October and November 1995 were recorded and released on the live album Thrakattak in May 1996, which is an hour of improvised music integrating sections from performances of Thrak's title track in the United States and Japan as mixed and arranged into a single work by David Singleton. A more conventional live recording from the period was later made available as the double CD release Vrooom Vrooom (2001), while a full 1995 concert was released on VHS in 1996 as Live in Japan and re-released on DVD in 1999 as Déjà Vrooom. The double trio would be further honoured by the Thrak (1994–1997) box set in 2015. The band began rehearsing again in May 1997 in Nashville, Tennessee.

The earliest known physical evidence of tea was discovered in 2016 in the mausoleum of Emperor Jing of Han in Xi'an, indicating that tea from the genus Camellia was drunk by Han dynasty emperors as early as the second century BC. The Han dynasty work "The Contract for a Youth", written by Wang Bao in 59 BC, contains the first known reference to boiling tea. Among the tasks listed to be undertaken by the youth, the contract states that "he shall boil tea and fill the utensils" and "he shall buy tea at Wuyang". The first record of tea cultivation is dated to this period, during which tea was cultivated on Meng Mountain (蒙山) near Chengdu. Another early credible record of tea drinking dates to the 3rd century AD, in a medical text by the Chinese physician Hua Tuo, who stated, "to drink bitter t'u constantly makes one think better." However, before the Tang dynasty, tea-drinking was primarily a southern Chinese practice centered in Jiankang. Tea was disdained by the Northern dynasties aristocrats, who describe it as inferior to yogurt. It became widely consumed during the Tang dynasty, when it spread to Korea, Japan, and Vietnam. The Classic of Tea, a treatise on tea and its preparations, was written by the 8th century Chinese writer, Lu Yu. The current Chinese word for tea (茶) appeared in The Classic of Tea by removing a stroke from the word tu. Lu was known to have influenced tea drinking on a large part in China.

3 Ca(OH)2 + 6 S → 2 CaS2 + CaS2O3 + 3 H2O where the S2−2 species corresponds to the disulfide anion −S−S− (with a covalent bond between the two sulfur atoms), also present in pyrite (FeS2), a Fe(II) disulfide mineral. They also successfully controlled this reaction to achieve the conversion of elemental sulfur into a quasi-pure solution of calcium thiosulfate.

Mescaline has been isolated from numerous cactus species, including Echinopsis (Trichocereus), Gymnocalycium, Lophophora, Opuntia, Stenocereus, and Turbinicarpus species, among others. It occurs at the highest known concentrations in Lophophora williamsii (peyote), where it is highly variable but makes up 0.1 to 0.255% fresh weight and 0.9 to 6.3% of dry weight. Levels of mescaline are much lower in other Lophophora species. The compound also occurs in relatively high concentrations in various Echinopsis species, for instance Echinopsis pachanoi (San Pedro cactus), ranging from 0.02 to 0.12% fresh weight and 0.331 to 2.0% dry weight in this species. Mescaline occurs in only small or trace amounts in most other cactus species in which it has been detected.

== Career == Hicks earned her bachelor's degree at Marshall University in 2001, and went on to earn her doctorate at the University of Illinois Urbana-Champaign in 2005. She was an Assistant Member and Principal Investigator at the Donald Danforth Plant Science Center from 2006 to 2013, and an adjunct professor in the Department of Biology at Washington University in St. Louis before beginning her current position as a professor at UNC. She was named Chancellor’s Science Scholars Term Professor in 2022.

Sources: en.wikipedia.org

Supporting material

Dimethocaine, also known as DMC or larocaine, is a compound with local anesthetic and stimulatory effects. The stimulatory effect resembles that of cocaine, although less potent. Similarly to cocaine, dimethocaine is addictive due to its stimulation of the reward pathway in the brain. However, dimethocaine is a legal cocaine replacement in some countries and is listed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) under the "synthetic cocaine derivatives" category. The structure of dimethocaine, being a 4-aminobenzoic acid ester, resembles that of procaine. It is found as a white powder at room temperature. When a product sold online in the UK in June 2010, advertised as dimethocaine was tested, it was found to be a mixture of caffeine and lidocaine, and the lack of any dopaminergic stimulant ingredient in such mixes may explain the limited recreational effects reported by many users. Other samples tested have however been shown to contain genuine dimethocaine, and one branded "bath salt" product containing primarily dimethocaine as the active ingredient, was noted to have been particularly subject to abuse by intravenous drug users in Ireland.

Action – Assassin's Creed: Brotherhood Artistic Achievement – God of War III Best Game – Mass Effect 2 Family – Kinect Sports Gameplay – Super Mario Galaxy 2 Handheld – Cut the Rope Multiplayer – Need for Speed: Hot Pursuit Original Music – Heavy Rain Puzzle – Rooms: The Main Building Social Network Game – My Empire Sports – F1 2010 Story – Heavy Rain Strategy – Civilization V Technical Innovation – Heavy Rain Use of Audio – Battlefield: Bad Company 2 BAFTA Ones to Watch Award (in association with Dare to Be Digital) – Twang! GAME Award of 2010 – Call of Duty: Black Ops Academy Fellowship – Peter Molyneux

An adnexal mass is a lump in the tissue of the adnexa of the uterus (structures which are closely related structurally and functionally to the uterus, such as the ovaries, fallopian tubes, or any of the surrounding connective tissue). Adnexal masses can be benign (noncancerous) or malignant (cancerous), and they can be categorized as simple or complex.

== Terminology == Buff – Having high amount of muscle mass Recovery – Resting time after workout to avoid muscle fatigue Reps – Short for repetitions, usually referred to strength training exercises Ripped – Having very low body fat percentage accompanied with high amount of muscle mass Sets – Repetitions done for certain amount followed by a period of rest Warm up – Initial exercises done to prepare for the main routine Workout – Routine of multiple exercises Gains - Muscle mass gained after a period of working out Nutritional Amino acid Creatine Dietary supplement Energy drink Formula Protein Snack bar Vitamin B12 Vitamin B2 Vitamin B6 Whey protein Biological Joint Muscle Muscle fiber Muscle tissue Tendon

Sources: en.wikipedia.org

Notes from published material

Aeroponics Anthroponics Aquaponics Digeponics Fogponics Folkewall Grow box Growroom Nutrient film technique Organoponics Passive hydroponics Plant factory Plant nutrition Plant pathology Root rot Vertical farming Xeriscaping

Article 23 provided the possibility for other parts of Germany to join the Federal Republic (under the constitution of the Federal Republic of Germany). Article 146 provided the possibility for unification of all parts of Germany under a new constitution. After the peaceful revolution of 1989 in East Germany, the Volkskammer of the GDR on 23 August 1990 declared the accession of East Germany to the Federal Republic under Article 23 of the Basic Law and thus initiated the process of reunification, to come into effect on 3 October 1990. Nevertheless, the act of reunification itself (with its many specific terms and conditions; including fundamental amendments to the West German Basic Law) was achieved constitutionally by the subsequent Unification Treaty of 31 August 1990; that is through a binding agreement between the former GDR and the Federal Republic now recognising each another as separate sovereign states in international law. This treaty was then voted into effect on 20 September 1990 by both the Volkskammer and the Bundestag by the constitutionally required two-thirds majorities; effecting on the one hand, the extinction of the GDR and the re-establishment of Länder on the territory of East Germany; and on the other, the agreed amendments to the Basic Law of the Federal Republic. Amongst these amendments was the repeal of the very Article 23 in respect of which the GDR had nominally declared its postdated accession to the Federal Republic.

The spread of ironworking in Central and Western Europe is associated with Celtic expansion. According to Pliny the Elder, iron use was common in the Roman era. In the lands of what is now considered China, iron appears approximately 700–500 BC. Iron smelting may have been introduced into China through Central Asia. The earliest evidence of the use of a blast furnace in China dates to the 1st century AD, and cupola furnaces were used as early as the Warring States period (403–221 BC). Usage of the blast and cupola furnace remained widespread during the Tang and Song dynasties. During the Industrial Revolution in Britain, Henry Cort began refining iron from pig iron to wrought iron (or bar iron) using innovative production systems. In 1783 he patented the puddling process for refining iron ore. It was later improved by others, including Joseph Hall.

Sydenham's chorea, also known as rheumatic chorea, is a disorder characterized by rapid, uncoordinated jerking movements primarily affecting the face, hands and feet. Sydenham's chorea is an autoimmune disease that results from childhood infection with Group A beta-haemolytic Streptococcus. It is reported to occur in 20–30% of people with acute rheumatic fever and is one of the major criteria for it, although it sometimes occurs in isolation. The disease occurs typically a few weeks, but up to 6 months, after the acute infection, which may have been a simple sore throat (pharyngitis). Sydenham's chorea is more common in females than males, and most cases affect children between 5 and 15 years of age. Adult onset of Sydenham's chorea is comparatively rare, and the majority of the adult cases are recurrences following childhood Sydenham's chorea (although pregnancy and female hormone treatment are also potential causes). It is historically one of the conditions called St Vitus' dance.

==== In males ==== It is secreted from the Sertoli cells, located in the seminiferous tubules inside the testes. Androgens stimulate inhibin production; this protein may also help to locally regulate spermatogenesis.

Sources: en.wikipedia.org

Frequently asked questions

What is AOD-9604?

It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.

Is AOD-9604 the same as human growth hormone?

No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.

Does AOD-9604 occur naturally?

The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.

Network